Keyword Connections

voriconazole

Journals

8

1 Polymers

2 journal of chromatography b, analytical technologies in the biomedical and life sciences

3 Journal of pharmaceutical and biomedical analysis

4 British journal of clinical pharmacology

5 European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

6 Xenobiotica; the fate of foreign compounds in biological systems

7 journal of liposome research

8 journal of chemotherapy (florence, italy)

Research Groups

0

No Research Group Connected

Bibliographies

40

1 Chitosan-Graft-Poly(N-Isopropylacrylamide)/PVA Cryogels as Carriers for Mucosal Delivery of Voriconazole.

2 Prediction of the effect of voriconazole on the pharmacokinetics of non-steroidal anti-inflammatory drugs.

3 Impact of collagen-induced arthritis on the pharmacokinetic disposition of voriconazole, a widely used antifungal agent: in vitro and in vivo investigations in DBA/1J mice.

4 Edge activators and a polycationic polymer enhance the formulation of porous voriconazole nanoagglomerate for the use as a dry powder inhaler.

5 Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts' consensus recommendations.

6 a case presentation of voriconazole therapy in a brochopulmonary dysplasia

7 comparison of clinical pharmacology of voriconazole and posaconazole

8 Development of a new stability indicating method for the simultaneous separation of voriconazole from its impurities along with sodium benzoate used as a preservative in a powder for oral suspension.

9 Novel insights into the complex pharmacokinetics of voriconazole: a review of its metabolism.

10 UPLC-MS/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma.

11 Photosensitisation by voriconazole-N-oxide results from a sequence of solvent and pH-dependent photochemical and thermal reactions.

12 Relationship Between the CYP2C19 Phenotype Using the Voriconazole-to-Voriconazole N-Oxide Plasma Concentration Ratio and Demographic and Clinical Characteristics of Japanese Patients With Different CYP2C19 Genotypes.

13 Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics.

14 The efflux pump inhibitor tetrandrine exhibits synergism with fluconazole or voriconazole against Candida parapsilosis.

15 Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo

16 The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro

17 Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis

18 Update on the optimal use of voriconazole for invasive fungal infections

19 Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo

20 The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro

21 Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis

22 Update on the optimal use of voriconazole for invasive fungal infections

23 Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.

24 Development and validation of a volumetric absorptive microsampling assay for analysis of voriconazole and voriconazole N-oxide in human whole blood.

25 Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity.

26 Inflammation Due to Voriconazole-induced Photosensitivity Enhanced Skin Phototumorigenesis in Xpa-knockout Mice.

27 Voriconazole metabolism is influenced by severe inflammation: a prospective study.

28 Saturated Metabolism of Voriconazole N-Oxidation Resulting in Nonlinearity of Pharmacokinetics of Voriconazole at Clinical Doses.

29 Voriconazole tolerability in lung transplant recipients: Is N-oxide metabolite responsible for phototoxicity?

30 Voriconazole N-oxide and its ultraviolet B photoproduct sensitize keratinocytes to ultraviolet A.

31 Targeted Aspergillus Prophylaxis With Voriconazole in Heart Transplant Patients: A Focus on the Interaction With Tacrolimus

32 Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.

33 Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.

34 Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019.

35 Voriconazole: a new triazole antifungal agent

36 Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

37 brown heroin-associated candida albicans ventriculitis and endopthalmitis treated with voriconazole

38 corneal debridement combined with intrastromal voriconazole for recalcitrant fungal keratitis

39 argon laser photocoagulation versus intrastromal voriconazole injection in treatment of mycotic keratitis

40 Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole